T. Sorlie, C. M. Perou, and R. Tibshirani, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc Nat Acad Sci, vol.98, pp.10869-10874, 2001.

N. Harbeck and M. Gnant, Breast cancer. Lancet, vol.389, pp.1134-1150, 2016.

B. D. Lehmann, J. A. Bauer, and X. Chen, Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies, J Clin Investig, vol.121, issue.7, pp.2750-2767, 2011.

G. Bianchini, J. M. Balko, I. A. Mayer, M. E. Sanders, and L. Gianni, Triplenegative breast cancer: challenges and opportunities of a heterogeneous disease, Nat Rev Clin Oncol, vol.13, issue.11, pp.674-690, 2016.

G. Palma, G. Frasci, and A. Chirico, Triple negative breast cancer: looking for the missing link between biology and treatments, Oncotarget, vol.6, issue.29, pp.26560-26574, 2015.

M. D. Burstein, A. Tsimelzon, and G. M. Poage, Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer, Clin Cancer Res, vol.21, issue.7, pp.1688-1698, 2015.

B. D. Lehmann, B. Jovanovic, and X. Chen, Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection, PLoS ONE, vol.11, issue.6, p.157368, 2016.

W. D. Foulkes, I. E. Smith, and J. S. Reis-filho, Triple-negative breast cancer, N Engl J Med, vol.363, issue.20, pp.1938-1948, 2010.
URL : https://hal.archives-ouvertes.fr/hal-02463255

C. Denkert, C. Liedtke, A. Tutt, and G. Von-minckwitz, Molecular alterations in triple-negative breast cancer-the road to new treatment strategies, Lancet, vol.389, pp.2430-2442, 2016.

H. Yao, G. He, and S. Yan, Triple-negative breast cancer: is there a treatment on the horizon?, Oncotarget, vol.8, issue.1, pp.1913-1924, 2016.

F. Shao, H. Sun, and C. X. Deng, Potential therapeutic targets of triplenegative breast cancer based on its intrinsic subtype, Oncotarget, vol.8, issue.42, pp.73329-73344, 2017.

A. A. Jitariu, A. M. Cimpean, D. Ribatti, and M. Raica, Triple negative breast cancer: the kiss of death, Oncotarget, vol.8, issue.28, pp.46652-46662, 2017.

T. Yang and B. O. Williams, Low-density lipoprotein receptor-related proteins in skeletal development and disease, Physiol Rev, vol.97, issue.3, pp.1211-1228, 2017.

C. Lane-donovan and J. Herz, The ApoE receptors Vldlr and Apoer2 in central nervous system function and disease, J Lipid Res, vol.58, issue.6, pp.1036-1043, 2017.

A. H. Assadi, G. Zhang, and U. Beffert, Interaction of reelin signaling and Lis1 in brain development, Nat. Genet, vol.35, issue.3, pp.270-276, 2003.

J. Kim, H. Yoon, J. Basak, and J. Kim, Apolipoprotein E in synaptic plasticity and Alzheimer's disease: potential cellular and molecular mechanisms, Mol Cells, vol.37, issue.11, pp.767-776, 2014.

J. Zhang, X. Zhang, L. Zhang, F. Zhou, and M. Van-dinther, Ten Dijke P. LRP8 mediates Wnt/beta-catenin signaling and controls osteoblast differentiation, J Bone Miner Res, vol.27, issue.10, pp.2065-2074, 2012.

C. Garnis, J. Campbell, J. J. Davies, C. Macaulay, S. Lam et al., Involvement of multiple developmental genes on chromosome 1p in lung tumorigenesis, Hum Mol Genet, vol.14, issue.4, pp.475-482, 2005.

N. Pencheva, H. Tran, and C. Buss, Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis, Cell, vol.151, issue.5, pp.1068-1082, 2012.

M. F. Tavazoie, I. Pollack, and R. Tanqueco, LXR/ApoE activation restricts innate immune suppression in cancer. Cell, vol.172, pp.825-840, 2018.

B. Arun, C. Shiang, and Y. Qi, High throughput siRNA Screen Identifies LRP8 as druggable metabolic regulator in triple-negative breast cancer, SM J Oncol Hematol, vol.1, issue.1, p.1003, 2016.

V. Maire, C. Baldeyron, and M. Richardson, TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer, PLoS ONE, vol.8, issue.5, p.63712, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01190560

V. Maire, F. Nemati, and M. Richardson, Polo-like kinase 1: a potential therapeutic option in combination with conventional chemotherapy for the management of patients with triple-negative breast cancer, Can Res, vol.73, issue.2, pp.813-823, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01190661

S. Maubant, B. Tesson, and V. Maire, Transcriptome analysis of Wnt3a-treated triple-negative breast cancer cells, PLoS ONE, vol.10, issue.4, p.122333, 2015.

C. Baldeyron, A. Brisson, and B. Tesson, TIPIN depletion leads to apoptosis in breast cancer cells, Mol Oncol, vol.9, issue.8, pp.1580-1598, 2015.

, Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours, Nature, vol.490, issue.7418, pp.61-70, 2012.

C. Curtis, S. P. Shah, and S. F. Chin, The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups, Nature, vol.486, issue.7403, pp.346-352, 2012.

A. S. Hamy, H. Bonsang-kitzis, and M. Lae, A stromal immune module correlated with the response to neoadjuvant chemotherapy, prognosis and lymphocyte infiltration in HER2-positive breast carcinoma is inversely correlated with hormonal pathways, PLoS ONE, vol.11, issue.12, p.167397, 2016.

B. Marty, V. Maire, and E. Gravier, Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells, Breast Cancer Res, vol.10, issue.6, p.101, 2008.

P. Workman, E. O. Aboagye, and F. Balkwill, Guidelines for the welfare and use of animals in cancer research, Br J Cancer, vol.102, issue.11, pp.1555-1577, 2010.

S. Maubant, T. Tahtouh, and A. Brisson, LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers, Oncotarget, vol.9, issue.32, pp.22586-22604, 2018.

T. D. King, M. J. Suto, and Y. Li, The Wnt/beta-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer, J Cell Biochem, vol.113, issue.1, pp.13-18, 2012.

S. G. Pohl, N. Brook, M. Agostino, F. Arfuso, A. P. Kumar et al., Wnt signaling in triple-negative breast cancer, Oncogenesis, vol.6, issue.4, p.310, 2017.

G. Ciriello, M. L. Gatza, and A. H. Beck, Comprehensive molecular portraits of invasive lobular breast cancer, Cell, vol.163, issue.2, pp.506-519, 2015.

F. Fauteux, J. J. Hill, and M. L. Jaramillo, Computational selection of antibody-drug conjugate targets for breast cancer, Oncotarget, vol.7, issue.3, pp.2555-2571, 2016.